EUVIMEDEUVIMED entdecken
Crossref

New Sinomenine Derivative as a Potential Drug for Cervical Cancer via Inducing Ferroptosis

Yifan Shang, Keran Li, Wenting Liu, Yixuan Wang, Huixian Zhou iD, Yongqian Liu, Tianqin Xiong, Tao Wang

Archiv der Pharmazie · 2026-02 · 359 (2)

DOI: 10.1002/ardp.70218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 01.03.2026. Verfasst von Yifan Shang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Morphinans, Uterine Cervical Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: The fundamental research fund for "double first-class universities" of Guangzhou University of Chinese Medicine, Grant/Award Number: 2021xk87; The Undergraduat….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer remains a serious threat to women's health due to chemotherapy resistance, poor prognosis, and survival rates. Novel anti‐cervical cancer agents are urgently needed. Sinomenine derivatives, which were prepared from sinomenine (a natural morphinane alkaloid), have been previously reported by us to be cytotoxic toward various cancer cell lines. Also, an increase in ROS production, which is associated with ferroptosis, was observed in cancer cells. In this study, we synthesized 18 sinomenine derivatives and evaluated their antitumor activity in vitro against four human tumor cell lines (HeLa, HepG2, A549, and HT‐29). Five derivatives ( 12 – 16 ) containing quinoline fragments showed broad‐spectrum antitumor activity. Significantly, 16 showed specific activity against HeLa and HT‐29 cells, with IC 50 values of 5.60 and 7.60 μM, respectively. Its optimal lipophilicity (−1 < log P < 2) likely contributes to this efficacy. Further study in vitro showed that Derivative 16 could increase the accumulation of ferrous iron, which caused an increase in ROS levels and MDA contents, and a decrease in GPX4 activity. Western blot results showed that 16 decreased the FHTI‐to‐GAPDH, SLC7A11‐to‐GAPDH, and GPX4‐to‐GAPDH ratios. Molecular docking simulation results suggested that 16 can interact with ferroptosis‐related proteins via the van der Waals force, and cation–π, anion–π, and hydrogen bonding interactions. In brief, Compound 16 may be a potentially useful drug for the treatment of cervical cancer, as it induces ferroptosis in HeLa cells by inhibiting FTH1 expression and the SLC7A11/GSH/GPX4 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMorphinansUterine Cervical NeoplasmsAntineoplastic AgentsHumansFemaleStructure-Activity RelationshipReactive Oxygen SpeciesDrug Screening Assays, AntitumorDose-Response Relationship, DrugMolecular StructureCell ProliferationCell Line, TumorMolecular Docking Simulation

Stichwörter der Autor:innen

GPX4antitumor activitycervical cancerferroptosissinomenine derivative

Substanzen

MorphinanssinomenineAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
  • Department of Pharmaceutical Equipment, Yangchun Hospital of Traditional Chinese Medicine, Yangchun, Guangdong, People's Republic of China.
  • Department of Pharmacy, Guangdong Women and Children Hospital, Guangzhou, Guangdong, People's Republic of China.

ORCID-Profile: Huixian Zhou

Förderung

  • The fundamental research fund for "double first-class universities" of Guangzhou University of Chinese Medicine, Grant/Award Number: 2021xk87; The Undergraduat…

Zitieren

APA

Shang, Y., Li, K., Liu, W., Wang, Y., Zhou, H., Liu, Y., Xiong, T., & Wang, T. (2026). New Sinomenine Derivative as a Potential Drug for Cervical Cancer via Inducing Ferroptosis. Archiv der Pharmazie, 359(2). https://doi.org/10.1002/ardp.70218

Vancouver

Shang Y, Li K, Liu W, Wang Y, Zhou H, Liu Y, et al. New Sinomenine Derivative as a Potential Drug for Cervical Cancer via Inducing Ferroptosis. Archiv der Pharmazie. 2026;359(2). doi:10.1002/ardp.70218

BibTeX
@article{Shang2026,
  author = {Shang, Yifan and Li, Keran and Liu, Wenting and Wang, Yixuan and Zhou, Huixian and Liu, Yongqian and Xiong, Tianqin and Wang, Tao},
  title = {New Sinomenine Derivative as a Potential Drug for Cervical Cancer via Inducing Ferroptosis},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {2},
  doi = {10.1002/ardp.70218}
}
Kostenlos starten →